Bausch + Lomb Features More Than 30 Scientific Presentations at Optometry’s Meeting® and the 5th World Congress of Optometry

Monday, June 23 2025 | 10 h 10 min | News

Bausch + Lomb Corporation announced 11 live presentations and 22 poster presentations at Optometry’s Meeting the annual American Optometric Association (AOA) Congress, and the 5th World Congress of Optometry (WCO) taking place in Minneapolis, MN June 25-28, 2025. The company also sponsored several educational events.

Of the live presentations, two were recognized as a Top Five Poster and a Top Presentation at this year’s meeting by the AOA and WCO respectively: an analysis of Bausch + Lomb ULTRA^® monthly lenses and an  overview of early clinical experience and market adoption of MIEBO^® (perfluorohexyloctane ophthalmic solution), which is indicated for the treatment of the signs and symptoms of dry eye disease.

Additional live presentations and posters will feature data across key products in the company’s broad eye care portfolio. These include XIIDRA^® (lifitegrast ophthalmic solution) 5%, which is indicated to treat the signs and symptoms of dry eye disease, LUMIFY^® Preservative Free redness reliever eye drops, Zenlens^®, a custom scleral contact lens technology designed to fit a wide variety of corneal shapes and sizes, Blink^® Nourish and Blink Boost lubricating eye drops for dry eyes and Blink™ NutriTears^® clinically proven nutritional supplement for dry eyes*.

See below for the complete list of Bausch + Lomb scientific presentations and events.

Live Presentations

• “Coverage of Ametropia with a Planned Replacement Soft Contact Lens Portfolio.” Luensmann D.
• “Early Patient-Reported Satisfaction in Patients Initiated on Perfluorohexyloctane for Dry Eye Disease.” Quint J.
• “Early Symptom Relief and Satisfaction with Perfluorohexyloctane Ophthalmic Solution in Dry Eye Disease: a Prospective, Open-Label, Multicenter Study.” Lang J.
• “Impact on Intraocular Pressure After Switching to Latanoprostene Bunod Among Patients with Glaucoma in Real-World Clinical Practice.” Cothran N.

Live In Person Poster Presentations

• “Addressing Ocular Redness and Other Cosmetic Concern: Insights from a Survey of U.S. Optometrists.” Cerenzia W.
• “Early Symptom Relief with Lifitegrast Ophthalmic Solution, 5.0% in Patients with Dry Eye Disease: A Post-Hoc Analysis of Two Randomized Clinical Trials.” Koetting C.
• “Effect of the Dry Eye Drop Perfluorohexyloctane and Comparator Semifluorinated Alkanes on the Evaporation.” Borchman D.
• “Early Adoption and Utilization of Perfluorohexyloctane Ophthalmic Solution for Dry Eye Disease.” Brimer C.
• “Early Patient-Reported Satisfaction in Patients Initiated on Perfluorohexyloctane for Dry Eye Disease.” Quint J.
• “Intervening in the Dry Eye Inflammatory Cycle with a Daily Oral Nutritional Supplement.” Gioia N.
• “Real-World Evaluation of Practitioner Satisfaction with a Novel Daily Disposable Silicone Hydrogel Toric Contact Lens: Study Summary and Early Experience.” Womack J.

Digital Presentations

• “A Multi-Country Assessment of a Custom Scleral Lens System: Eyecare Practitioner Clinical Experience and Satisfaction.” Messer B.
• “A Multi-Country Assessment of a Custom Scleral Lens System: Real-World Clinical Outcomes.” Gildea C.
• “Analysis of Real-World Prescribing Patterns of Brimonidine Tartrate Ophthalmic Solution 0.025%.” Quint J.
• “A Real-World Multi-Country Assessment of a Custom Scleral Lens System: MicroVault Technology Sub-analysis.” Gidosh N.
• “A Real-World Multi-Country Assessment of a Custom Scleral Lens System: Multifocal Lens Sub-analysis.” Hoffman K.
• “Comparative Analysis of the Antioxidant Effects of a Novel Over-the-Counter Dry Eye Drop on Human Corneal Epithelial Cells.” McGee S.
• “Comparative Analysis of the Osmoprotective Effects of Over-the-Counter Dry Eye Formulations on Human Corneal Epithelial Cells.” Koetting C.
• “Conjunctival Hyperemia: a Multi-Country Assessment of Health Care Professionals’ Perspectives on the Treatment Landscape.” Wesley G.
• “Evaluation of a Novel Preservative-Free Formulation of Brimonidine Tartrate Ophthalmic Solution for the Treatment of Conjunctival Hyperemia.” McGee S.
• “Fitting Success Rates with a Unique Daily Disposable Multifocal Contact Lens: a Multicenter Clinical Study.” Holland Z.
• “Patient and Eyecare Professional Satisfaction with Kalifilcon a Spherical Daily Disposable Contact Lenses for Existing Planned Replacement Soft Contact Lens Wearers.” Lang J.
• “Real-World Assessment of a Multi-Purpose Contact Lens Solution Among Excessive Contact Lens Wearers.” Schaeffer M.
• “Real-World Assessment of a Novel Multi-Purpose Contact Lens Solution Among Hydrogen Peroxide Lens Care Users with Lens Dryness.” Nguyen C.
• “Real-World Clinical Experience with a Custom Scleral Lens System, Utilizing Two Distinct Sagittal Depth Values to Address Limbal Asymmetry.” Kuzniar J.
• “Real-World Evaluation of Patient Satisfaction with a Novel Daily Disposable Silicone Hydrogel Toric Contact Lens: Study Summary and Early Experience.” Wesley G.
• “Real-World Experience with Lifitegrast Ophthalmic Solution in Patients with Dry Eye Disease: a Provider Survey.” Barnett M.
• “Real-World Patient and Eyecare Professional Satisfaction with a Multifocal Toric Silicone Hydrogel Monthly Contact Lens: Existing Contact Lens Wearers.” Bhagat K.
• “Real-World Patient Satisfaction with a Multifocal Toric Silicone Hydrogel Monthly Contact Lens: Prior Spectacle Wearers.” Bhagat K.
• “Scleral Lens Fitting in a Patient with Keratoconus and a History of Cataract, Corneal Transplant, and Bleb-Forming Glaucoma Surgery.” Harsch A.
• “Scleral Lens Fitting in a Patient with Keratoconus with Prior Corneal Crosslinking: Utilization of Bi-Elevation and MicroVault Technology.” Messer B.
• “The Design and Fit of a Scleral Lens in a Patient with a Post-Graft Cornea Using Optical Coherence Tomography and Scleral Profilometry.” Kuzniar J.
• “Utilization of Customizable Toric Peripheral Curves to Optimize Scleral Lens Fit and Vision Outcomes in Patients with Irregular Astigmatism and Corneal Complexities.” Hoffman K.

Thursday, June 26
Managing Patients with Both Glaucoma and Dry Eye Disease

• 8:00 – 9:00 a.m. CT; Minneapolis Convention Center; Room 101 DE
• Speakers: Nora Lee Cothran, OD, FAAO; Nate Lighthizer, OD, FAAO

Case Presentations: A Family of Eye Care Products with Innovations for Every Stage of Life

• 12:00 – 1:00 p.m. CT; Minneapolis Convention Center; Room 101 DE
• Speaker: Selina McGee, OD, FAAO; Mark Schaeffer, OD, FAAO; John Womack, OD

Friday, June 27
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition

• 8:00 – 9:00 a.m. CT; Minneapolis Convention Center; Room 101 DE
• Speakers: Jade Coats, OD, FAAO; Derek Cunningham, OD, FAAO

Saturday, June 28
AREDS: A Summary of Recent Clinical Updates

• 8:00 – 9:00 a.m. CT; Minneapolis Convention Center; Room 101 DE
• Speaker: Jeff Gerson, OD, FAAO

The Puzzle of Dry Eye: Targeted Approaches to a Multifactorial Condition

• 12:00 – 1:00 p.m. CT; Minneapolis Convention Center; Room 101 DE
• Speakers: Cecelia Koetting, OD, FAAO, DipABO; Selina McGee, OD, FAAO

Celebration of Optometry Event
For the second consecutive year, Bausch + Lomb is the title sponsor of AOA’s Celebration of Optometry event, taking place at Orchestra Hall and Peavey Plaza (1111 Nicollet Mall) at 7 p.m. CT on Friday, June 27. Attendees heared from Drs. Cecelia Koetting, OD, FAAO, DipABO, and Mile Brujic, OD, FAAO, on the company’s latest innovations, including Bausch + Lomb INFUSE^® daily disposable contact lenses and the company’s new preservative-free products, Blink Boost lubricating eye drops, Blink Nourish lubricating eye drops and LUMIFY Preservative Free redness reliever eye drops.

###

Important Safety Information for MIEBO

INDICATION
MIEBO (perfluorohexyloctane ophthalmic solution) is used to treat the signs and symptoms of dry eye disease.

IMPORTANT SAFETY INFORMATION

• MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO
• Instruct patients to instill one drop of MIEBO into each eye four times daily
• The safety and efficacy in pediatric patients below the age of 18 have not been established
• The most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness)

Click here for full Prescribing Information for MIEBO.

Important Safety Information for XIIDRA

Indication
Xiidra^® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).

Important Safety Information

• Xiidra is contraindicated in patients with known hypersensitivity to lifitegrast or to any of the other ingredients.
• In clinical trials, the most common adverse reactions reported in 5-25% of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
• To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
• Contact lenses should be removed prior to the administration of Xiidra and may be reinserted 15 minutes following administration.
• Safety and efficacy in pediatric patients below the age of 17 years have not been established.

Click here for full Prescribing Information for Xiidra.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information for Zenlens

WARNINGS:
Patients should be advised of the following warnings pertaining to contact lens wear:

• Problems with contact lenses and lens care products could result in serious injury to the eye. It is essential that patients follow their eyecare practitioner’s directions and all labeling instructions for proper use of lenses and lens care products, including the lens case. Eye problems, including corneal ulcers, can develop rapidly and lead to loss of vision.
• Daily wear lenses are not indicated for overnight wear, and patients should be instructed not to wear lenses while sleeping.
• Clinical studies have shown that the risk of serious adverse reactions is increased when daily wear lenses are worn overnight.
• Studies have shown that contact lens wearers who are smokers have a higher incidence of adverse reactions than nonsmokers.
• If a patient experiences eye discomfort, excessive tearing, vision changes, or redness of the eye, the patient should be instructed to immediately remove lenses and promptly contact his or her eyecare practitioner.

CONTRAINDICATIONS:
Do not use when any of the following conditions exist:

• Acute or subacute inflammation or infection of the anterior chamber of the eye
• Any eye disease, injury or abnormality, other than keratoconus, PMD, that affects the cornea, conjunctiva or eyelids
• Severe insufficiency of lacrimal secretion (dry eye)
• Corneal hypoesthesia (reduced sensitivity), if not aphakic
• Any systemic disease that may affect the eye or be exaggerated by wearing contact lenses
• Allergic reactions of ocular surfaces or adnexa that may be induced or exaggerated by wearing contact lenses or using contact lens solutions
• Allergy to any ingredient in a solution which is to be used to care for contact lenses
• Any active corneal infection (bacterial, fungal or viral)
• Red or irritated eyes

ADVERSE EFFECTS:
The following problems may occur with the use of contact lenses:

• Eyes stinging, burning, itching, irritation or other eye pain
• Comfort is less than when the lens was first placed on the eye
• Feeling of something in the eye such as a foreign body, scratched area
• Excessive watering (tearing) of the eye
• Unusual eye secretions Redness of the eyes
• Reduced sharpness of vision (poor visual acuity)
• Blurred vision, rainbows, or halos around objects
• Sensitivity to light (photophobia)
• Dry eyes

Source: Bausch + Lomb  

Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!